12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga · 07/23 12:06
Gainers
- Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million.
- Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 20.28% to $1.66. The market value of their outstanding shares is at $65.4 million.
- First Tracks (NASDAQ:TRAX) stock rose 19.43% to $45.59. The company's market cap stands at $1.3 billion.
- Medpace Holdings (NASDAQ:MEDP) stock increased by 18.46% to $625.62. The company's market cap stands at $15.0 billion. As per the news, the Q2 earnings report came out yesterday.
- GMR Solutions (NYSE:GMRS) stock moved upwards by 15.62% to $14.8. The market value of their outstanding shares is at $691.3 million.
- NovoCure (NASDAQ:NVCR) shares increased by 13.3% to $17.64. The market value of their outstanding shares is at $1.8 billion. As per the news, the Q2 earnings report came out today.
Losers
- China SXT Pharmaceuticals (NASDAQ:SXTC) stock declined by 25.7% to $1.5 during Thursday's pre-market session. The company's market cap stands at $77.2 million.
- Nuwellis (NASDAQ:NUWE) stock fell 16.5% to $2.38.
- SANUWAVE Health (NASDAQ:SNWV) shares decreased by 14.12% to $5.11. The market value of their outstanding shares is at $51.1 million.
- Community Health System (NYSE:CYH) shares declined by 13.05% to $2.8. The market value of their outstanding shares is at $453.7 million. As per the press release, Q2 earnings came out yesterday.
- MindWalk Holdings (NASDAQ:HYFT) stock decreased by 12.5% to $1.26. The company's market cap stands at $67.2 million. As per the press release, Q4 earnings came out yesterday.
- Autonomix Medical (NASDAQ:AMIX) shares fell 12.07% to $3.5. The market value of their outstanding shares is at $2.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.